GlassScriptPhysician profile
Malcolm W Hickox
NPI 1457385171
$4,672.00
in general payments reported to CMS, 2019-2025
40 companies · $386 in 2025
The $386 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,809 · 2023: $1,064 · 2024: $1,413 · 2025: $386.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,863.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,862.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $554.92 | 2022-2025 | |
| Lilly USA, LLC | $472.37 | 2022-2025 | Mounjaro, Jardiance, Zepbound |
| Novo Nordisk INC | $437.72 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Glaxosmithkline, LLC. | $401.80 | 2022-2024 | Trelegy Ellipta, Arexvy, Shingrix |
| Amgen INC. | $348.56 | 2022-2023 | Otezla, Repatha |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $255.71 | 2022-2025 | Xifaxan, Trulance |
| Bayer Healthcare Pharmaceuticals INC. | $184.42 | 2022-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $161.50 | 2022-2024 | Synjardy, Jardiance |
| Painteq LLC | $150.00 | 2024 | Painteq |
| Abbott Laboratories | $145.42 | 2022-2025 | Freestyle Libre 3 |
| Phathom Pharmaceuticals, INC. | $136.68 | 2024-2025 | Voquezna |
| Sanofi-Aventis U.S. LLC | $121.37 | 2022-2024 | |
| Exact Sciences Corporation | $109.66 | 2023-2024 | Cologuard Collection Kit |
| Alnylam Pharmaceuticals INC. | $93.93 | 2024 | Amvuttra |
| Takeda Pharmaceuticals U.S.A., INC. | $88.30 | 2022 |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Malcolm Hickox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.